Related Experiment Video
Updated: Jul 11, 2025
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Advances in Treatment of Diffuse Midline Gliomas
Chantel Cacciotti1, Karen D Wright2
1Children's Hospital London Health Sciences/Western University, London, ON, Canada. Chantel.Cacciotti@lhsc.on.ca.
Purpose Of Review:
Diffuse midline gliomas (DMGs) generally carry a poor prognosis, occur during childhood, and involve midline structures of the central nervous system, including the thalamus, pons, and spinal cord.
Recent Findings:
To date, irradiation has been shown to be the only beneficial treatment for DMG. Various genetic modifications have been shown to play a role in the pathogenesis of this disease. Current treatment strategies span targeting epigenetic dysregulation, cell cycle, specific genetic alterations, and the immune microenvironment. Herein, we review the complex features of this disease as it relates to current and past therapeutic approaches.
